Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Jumped Today


Shares of Moderna (NASDAQ: MRNA) climbed on Monday, following news that the biotech company had begun its phase 3 study of its COVID-19 vaccine candidate and received additional funding from the U.S. government.

By the close of trading, Moderna's stock price was up more than 9%.

Moderna disclosed on Sunday that the Biomedical Advanced Research and Development Authority (BARDA) would provide it with up to $472 million in additional funding to further the development of its experimental COVID-19 vaccine, mRNA-1273. Combined with BARDA's previous commitment for $483 million, Moderna has now been awarded a total of $955 million in U.S. government funding. 

Continue reading


Source Fool.com

Like: 0
Share

Comments